SHANG.FOS.PHARM.GR.H YC 1 (08HH) — Financial Flexibility Index
SHANG.FOS.PHARM.GR.H YC 1 (08HH) has a Financial Flexibility Index of 0.17x as of December 2025. Free cash flow of €9.66 Billion (operating CF €5.21 Billion minus capex €4.45 Billion) represents 0% of total liabilities (€58.21 Billion). Also explore SHANG.FOS.PHARM.GR.H YC 1 annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SHANG.FOS.PHARM.GR.H YC 1 Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for SHANG.FOS.PHARM.GR.H YC 1 across 5 annual periods. Check 08HH cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for SHANG.FOS.PHARM.GR.H YC 1 (2021–2025)
Year-by-year free cash flow to debt coverage for SHANG.FOS.PHARM.GR.H YC 1. For the full company profile including market capitalisation, see SHANG.FOS.PHARM.GR.H YC 1 (08HH) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | €9.66 Billion | €5.21 Billion | €58.21 Billion | ▲ +7.4% |
| 2024 | 0.15x | €8.89 Billion | €4.48 Billion | €57.53 Billion | ▲ +0.4% |
| 2023 | 0.15x | €8.75 Billion | €3.41 Billion | €56.85 Billion | ▼ -19.2% |
| 2022 | 0.19x | €10.11 Billion | €4.22 Billion | €53.05 Billion | ▼ -4.0% |
| 2021 | 0.20x | €8.91 Billion | €3.94 Billion | €44.93 Billion | — |